HQY — HealthEquity, Inc.

HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $334.6 million, up 7% year-over-year.
• Net Income: $49.7 million, an increase of 89% year-over-year; net income margin at 15%.
• Non-GAAP Net Income: $81.8 million, up 33%; non-GAAP net income per share at $0.95, a 38% increase.
• Adjusted EBITDA: $132.9 million, up 23% with an adjusted EBITDA margin of 40%.
• HSA Accounts: Added a record 550,000 HSAs in Q4, totaling 17.8 million accounts and $36 billion in assets.
• Share Repurchase: Over $300 million returned to shareholders in fiscal 2026, reducing diluted shares outstanding by approximately 3%.

2. Strategic Updates and Business Highlights

• Engagement and Growth: The company emphasized a flywheel model focusing on saving, spending, and investing through HSAs, with significant member engagement through a mobile platform (3.6 million downloads).
• Marketplace Launch: Introduced a marketplace for healthcare-related products, with early offerings in weight-loss programs, hormone replacement therapy, and wearables, aiming to enhance member engagement and create new revenue streams.
• Regulatory Environment: Positive changes in legislation, particularly the expansion of HSA eligibility to ACA bronze plan members, are expected to drive growth.
• AI Integration: AI is being embedded into member services to enhance user experience and operational efficiency, with expectations of improved service delivery and cost reductions.

3. Forward Guidance and Outlook

• Fiscal 2027 Guidance: Revenue projected between $1.405 billion and $1.415 billion; GAAP net income expected between $239 million and $246 million; non-GAAP net income projected between $392 million and $400 million; adjusted EBITDA forecasted between $618 million and $628 million.
• Interest Rate Expectations: Anticipated average yield on HSA cash assets is approximately 3.8% for fiscal 2027, with ongoing hedging strategies in place.

4. Challenges and Points of Concern

• Macro Environment: Despite strong performance, concerns remain regarding the broader economic backdrop, including potential impacts from job growth and healthcare affordability pressures.
• Competitive Landscape: While the company reported strong retention rates (over 98%), there is ongoing concern about competitive pressures and pricing strategies in the market.
• New Cohorts: The ACA-driven retail members are still in early stages, making it difficult to predict long-term engagement and contribution behaviors.

5. Notable Q&A Insights

• Gross Margin Expansion: Management highlighted significant gross margin improvements driven by reduced fraud costs and operational efficiencies, with expectations for continued margin growth as AI initiatives roll out.
• Marketplace Engagement: Early trends in the marketplace show positive engagement, but it is still too early to assess long-term impacts on revenue.
• ACA Cohort Conversion: The company is optimistic about converting ACA bronze plan members, viewing it as a significant growth opportunity, although it is still in the early stages of implementation.
• Investment Growth: There is a clear distinction between cash growth and investment growth in HSAs, with management emphasizing the importance of older accounts for driving investment behavior.

Overall, HealthEquity, Inc. demonstrated strong financial performance in Q4 2026, with strategic initiatives aimed at enhancing member engagement and expanding market reach, while navigating potential macroeconomic challenges and competitive pressures.